We are live on ! Find out more
SC

Sophrosyne Capital Portfolio holdings

AUM $11.5M
1-Year Est. Return 17.82%
This Fund
S&P 500
This Quarter Est. Return
+16.82%
1 Year Est. Return
+17.82%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$114M
AUM Growth
-$37M
Cap. Flow
-$42.8M
Cap. Flow %
-37.45%
Top 10 Hldgs %
55.88%
Holding
85
New
18
Increased
11
Reduced
34
Closed
19

Top Buys

Rank Stock Value
1
ARCT icon
Arcturus Therapeutics
ARCT
+$3.67M
2
FLNA
Filana Therapeutics
FLNA
+$3.22M
3
CYNI
CYAN INC COM
CYNI
+$2.12M
4
BEAT
BioTelemetry, Inc.
BEAT
+$2.04M
5
MNDT
Mandiant, Inc. Common Stock
MNDT
+$1.32M

Top Sells

Rank Stock Value
1
SIGA icon
SIGA Technologies
SIGA
+$4.46M
2
AVAV icon
AeroVironment
AVAV
+$4.42M
3
BDSI
BioDelivery Sciences International, Inc.
BDSI
+$4.02M
4
CALX icon
Calix
CALX
+$3.41M
5
SANW
S&W Seed Co
SANW
+$3.17M

Sector Composition

Rank Sector Weight
1 Healthcare 55.14%
2 Technology 27.01%
3 Communication Services 7.3%
4 Utilities 3.88%
5 Miscellaneous 3.23%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BEAT
1
DELISTED
BioTelemetry, Inc.
BEAT
$9.78M 8.57%
1,231,718
+218,400
+22% +$2.04M
ZLTQ
2
DELISTED
ZELTIQ Aesthetics, Inc.
ZLTQ
$9.62M 8.43%
508,904
-110,700
-18% -$1.58M
MSTR icon
3
Strategy Inc
MSTR
$54.6B
$7.41M 6.49%
596,630
-230,000
-28% -$2.71M
LSAK icon
4
Lesaka Technologies
LSAK
$391M
$6.17M 5.4%
706,466
-142,300
-17% -$1.51M
CALX icon
5
Calix
CALX
$2.37B
$6.16M 5.4%
639,165
-318,641
-33% -$3.41M
FLNA
6
Filana Therapeutics
FLNA
$44.6M
$6.15M 5.38%
180,717
+121,315
+204% +$3.22M
ARCT icon
7
Arcturus Therapeutics
ARCT
$460M
$5.77M 5.05%
45,768
+29,232
+177% +$3.67M
ARAY icon
8
Accuray
ARAY
$31.3M
$4.61M 4.04%
529,500
-20,900
-4% -$162K
BDSI
9
DELISTED
BioDelivery Sciences International, Inc.
BDSI
$4.09M 3.58%
694,962
-779,944
-53% -$4.02M
MEET
10
DELISTED
The Meet Group, Inc. Common Stock
MEET
$4.05M 3.54%
2,210,887
-384,152
-15% -$716K
PKT
11
DELISTED
PROCERA NETWORKS INC NEW COM STK (DE)
PKT
$3.79M 3.32%
252,090
-72,610
-22% -$1.05M
TLPH icon
12
Talphera
TLPH
$63.8M
$3.72M 3.26%
16,469
-10,720
-39% -$1.86M
PCYO icon
13
Pure Cycle
PCYO
$275M
$3.63M 3.18%
573,000
-96,436
-14% -$594K
DRRX
14
DELISTED
DURECT Corp
DRRX
$3.14M 2.75%
181,397
-17,555
-9% -$265K
AXGN icon
15
Axogen
AXGN
$2.78B
$2.83M 2.48%
631,607
-124,121
-16% -$504K
P
16
DELISTED
Pandora Media Inc
P
$2M 1.75%
75,200
-22,000
-23% -$603K
CSII
17
DELISTED
Cardiovascular Systems, Inc.
CSII
$1.95M 1.71%
56,941
-74,600
-57% -$2.17M
UI icon
18
Ubiquiti
UI
$35.9B
$1.95M 1.71%
42,463
-68,600
-62% -$2.73M
CYNI
19
DELISTED
CYAN INC COM
CYNI
$1.88M 1.64%
+354,699
New +$2.12M
STRM
20
DELISTED
Streamline Health Solutions
STRM
$1.6M 1.4%
15,320
+5,673
+59% +$623K
ENVI
21
DELISTED
ENVIVIO INC COM STK (DE)
ENVI
$1.59M 1.39%
466,022
+26,071
+6% +$78.5K
CUTR
22
DELISTED
Cutera, Inc.
CUTR
$1.57M 1.37%
154,089
-170,248
-52% -$1.6M
ARWR icon
23
Arrowhead Research
ARWR
$12.5B
$1.53M 1.34%
140,858
-153,725
-52% -$1.23M
MNDT
24
DELISTED
Mandiant, Inc. Common Stock
MNDT
$1.47M 1.29%
+33,700
New +$1.32M
ENT
25
DELISTED
Global Eagle Entertainment Inc.
ENT
$1.44M 1.26%
3,872
+3,020
+354% +$926K
1
2 3 4

Similar funds

SFM
Socratic Fund Management Short Hills, New Jersey $12M AUM 39.3% 1-Year Est. Return
IACGFA
IDG-Accel China Growth Fund Associates Central, Hong Kong $13.2M AUM 31.6% 1-Year Est. Return
LS
Lupo Securities Chicago, Illinois $13.3M AUM 1.59% 1-Year Est. Return
NGPI
N.G. Partners II Palo Alto, California $9.65M AUM 70.44% 1-Year Est. Return
AP
AGTC Partners Cambridge, Massachusetts $13.6M AUM 15.62% 1-Year Est. Return
GRP
Geologic Resource Partners Boston, Massachusetts $9.22M AUM 48.14% 1-Year Est. Return
NVPV
Norwest Venture Partners VIII Palo Alto, California $9.22M AUM
AC
Amiya Capital London, United Kingdom $14.3M AUM 4.61% 1-Year Est. Return

Sophrosyne Capital's Q4 2013 Portfolio in Review

As of Q4 2013, Sophrosyne Capital held 85 positions worth $114M, down 24% from $151M the previous quarter. Its ten largest holdings account for 56% of the portfolio.

Sophrosyne Capital withdrew a net $42.8M in Q4 2013, closing 19 positions and reducing 34 holdings. Its most notable exit was SIGA Technologies, an estimated $4.46M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 55% of assets, up from 50% a quarter earlier, followed by Technology and Communication Services.

Against the trend, Sophrosyne Capital opened a new position in CYAN INC COM worth $1.88M.

  • Sophrosyne Capital's largest Q4 2013 buy was CYAN INC COM: 354,699 shares worth $1.88M.
  • Sophrosyne Capital added most to Arcturus Therapeutics in Q4 2013, an estimated $3.67M increase.
  • Sophrosyne Capital's biggest Q4 2013 reduction was AeroVironment, cutting an estimated $4.42M.
  • Sophrosyne Capital fully exited SIGA Technologies in Q4 2013, selling an estimated $4.46M.
  • Sophrosyne Capital's ten largest holdings make up 56% of its $114M portfolio in Q4 2013.
  • Sophrosyne Capital opened 18 new positions and closed 19 in Q4 2013.
  • Sophrosyne Capital's portfolio value fell 24% quarter-over-quarter to $114M.

Based on Sophrosyne Capital's 13F filing for Q4 2013, filed 13 Feb 2014.